✦ LIBER ✦

Exenatide: An incretin mimetic for the treatment of type 2 diabetes mellitus

✍ Scribed by Jason L. Iltz; Danial E. Baker; Stephen M. Setter; R. Keith Campbell

Book ID: 116371848
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 907 KB
Volume: 28
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2006.05.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Incretin Mimetic Exenatide as a Mono

The Incretin Mimetic Exenatide as a Monotherapy in Patients with Type 2 Diabetes

✍ Nelson, Patric; Poon, Terri; Guan, Xuesong; Schnabel, Catherine; Wintle, Matthew 📂 Article 📅 2007 🏛 Mary Ann Liebert 🌐 English ⚖ 191 KB

Investigational treatments for Type 2 di

Investigational treatments for Type 2 diabetes mellitus: exenatide and liraglutide

✍ González, Claudio; Beruto, Valeria; Keller, Guillermo; Santoro, Silvina; Di Giro 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 183 KB

Incretin mimetics and DPP-IV inhibitors

Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetes

✍ Loretta L. Nielsen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Incretin Mimetics and Dipeptidyl Peptida

Incretin Mimetics and Dipeptidyl Peptidase-IV Inhibitors: Potential New Therapies for Type 2 Diabetes Mellitus

✍ Curtis Triplitt; Alison Wright; Elaine Chiquette 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

Management of type 2 diabetes: the role

Management of type 2 diabetes: the role of incretin mimetics

✍ John H. Holcombe; Dennis D. Kim; Anthony H. Stonehouse; David M. Kendall 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Abstract Current strategies for the treatment of type 2 diabetes target deficient insulin secretion and insulin resistance, but have not been shown to correct the progressive β–cell dysfunction characteristic of the disease. Traditionally, type 2 diabetes is treated in a stepwise manner with med

Incretin Mimetics and DPP-IV Inhibitors:

Incretin Mimetics and DPP-IV Inhibitors: New Paradigms for the Treatment of Type 2 Diabetes

✍ Hinnen, D.; Nielsen, L. L.; Waninger, A.; Kushner, P. 📂 Article 📅 2006 🏛 American Board of Family Medicine 🌐 English ⚖ 102 KB